Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Apr 29;13(4):956-960.
doi: 10.21037/tlcr-24-10. Epub 2024 Apr 24.

Small cell, big promises: targeting small cell lung cancer with CAR T cells

Estela Noguera-Ortega  1   2 , Steven M Albelda  1   2
Affiliations
Editorial

Small cell, big promises: targeting small cell lung cancer with CAR T cells

Estela Noguera-Ortega et al. Transl Lung Cancer Res. .
No abstract available

Keywords: Small cell lung cancer (SCLC); chimeric antigen receptor T cells (CAR T cells); delta-like ligand-3 (DLL3).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tlcr.amegroups.com/article/view/10.21037/tlcr-24-10/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Del Bufalo F, De Angelis B, Caruana I, et al. GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma. N Engl J Med 2023;388:1284-95. 10.1056/NEJMoa2210859 - DOI - PubMed
    1. Mackensen A, Haanen JBAG, Koenecke C, et al. CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial. Nat Med 2023;29:2844-53. 10.1038/s41591-023-02612-0 - DOI - PMC - PubMed
    1. Albelda SM. CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn. Nat Rev Clin Oncol 2024;21:47-66. 10.1038/s41571-023-00832-4 - DOI - PubMed
    1. Zhang Y, Tacheva-Grigorova SK, Sutton J, et al. Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in Preclinical Models of Small Cell Lung Cancer. Clin Cancer Res 2023;29:971-85. 10.1158/1078-0432.CCR-22-2293 - DOI - PubMed
    1. Depil S, Duchateau P, Grupp SA, et al. 'Off-the-shelf' allogeneic CAR T cells: development and challenges. Nat Rev Drug Discov 2020;19:185-99. 10.1038/s41573-019-0051-2 - DOI - PubMed